CMI Communications

CMI Communications, ESCMID's open-access journal, is active on other platforms. Find us on Bluesky (@cmicomms.bsky.social / #IDSky), LinkedIn, and Instagram.

[CMI Communications @CMIComms]

CMI Communications is active on:

#Bluesky 🦋, where the ID/clinical microbio community is growing fast (@cmicomms.bsky.social / #IDSky)
LinkedIn
Instagram

Thank you for your support! 🙏
#IDtwitter #IDXposts #OpenAccess

[CMI Communications @CMIComms]

CMI Comms will no longer be posting on X. We hope to see you on #Bluesky 🦋, where the ID/clinical microbio community is growing fast (@cmicomms.bsky.social / #IDSky), or on LinkedIn or Instagram. Thank you for your support! 🙏
#IDtwitter #IDXposts #OpenAccess

[CMI Communications @CMIComms]

Though we all expected it, here is some of the first population-level evidence that post-pandemic antibiotic use bounced back fast to pre-pandemic levels (🙏Catherine @PlussSuard et al / 🙏reviewers).
#IDtwitter #IDXposts #OpenAccess @ABsteward @ESCMID
https://t.co/qgS36LTDiv

[SIDP @SIDPharm]

One week until these ID A-listers take the stage at the 2024 SIDP Annual Meeting! 🌴 💊 🦠 Swipe for full meeting schedule. Virtual registration still available!

Hear from Drs. @MikeMndudley @dianapark703 @lacymycin @mattdavis138 @amylcarr @priyanori & Ryan Tomlin #IDWeek2024

[ESCMID @ESCMID]

Past ESCMID President Annelies Zinkernagel gives her views on how our society has grown and evolved since the world of infectious diseases was thrust into the spotlight following the COVID-19 pandemic.
#ESCMID #COVID-19 #InfectiousDiseases

[CMI Communications @CMIComms]

@GermHunterMD @ESCMID Thank you! (Audience, not base.) Maybe for proofs they'll do repeating headers for rushed readers. ;-)
We are a bit protective of ESCMID & its good work... And though the authors didn't contact us, they're right that a big part of Communicable's audience is US-based. :-)

[CMI Communications @CMIComms]

Good compilation, thanks. But #Communicable is not a US-based podcast. It's @ESCMID's, so...
#idxposts #idtwitter

[Marc Bonten @MarcBonten]

Fall! Fresh start of the week with a nice publication (later today, I think) and 2 podcast recordings, starting this morning for @CMIComms on the Wild West in publishing (predator journals e.g.) with @LeonardLeibovi1, Angela Hunter and Ursula Hofer.

[CMI Communications @CMIComms]

★ Just published: #Communicable podcast episode - The Nightmare Series, part 2: How to deal with carbapenemase producers. Angela @ThomasTangden @KanjSouha & David Paterson @davidantibiotic discuss these nightmare organisms

Listen: https://t.co/zEMXwEcBCE

#IDtwitter #IDxposts

[CMI Communications @CMIComms]

On Monday we are releasing a new #Communicable podcast episode - the 2nd round of the Nightmare Series. Angela & @ThomasTangden sit down w/ David Patterson & @KanjSouha to discuss clinical challenges of dealing w/ carbapenemase producers. Swipe for preview!

#IDtwitter #IDxposts

[CMI Communications @CMIComms]

In 630 patients w/ cardiac implantable e-device & #bacteraemia, E. coli most common (26%) but caused 0 #CIED infections; S. aureus less common (21%) but caused 63% of CIED infections

Read full article: https://t.co/hPROsuDQn0

#IDtwitter #IDxposts @essiryodi

[SIDP @SIDPharm]

SIDP is thrilled to announce the launch of our new Breakpoints – The SIDP Podcast website!

The Breakpoints website is your 1st stop for all things Breakpoints podcast. Share with your fellow Breakpoints audiophiles to stay up to date!

Click here: https://t.co/KhRkJbPfRE!

[CMI Communications @CMIComms]

Dr @danyeoh & colleagues on CT imaging of invasive mold infections in immunocompromised children: nodules & halo sign most common but no one feature predicts causative pathogen ➡️ microbiological sampling remains essential

https://t.co/wnwThGbebp

@ABsteward #IDtwitter #IDxposts

[CMI Communications @CMIComms]

★ Just published: #Communicable podcast episode “Pipeline update: #newantibiotics & other #antimicrobials that you might actually use”

@ErinMcCreary, Markus Zeitlinger (@EMA_News) & @MikeMndudley (@Qpexbio) unpack what's to come!

https://t.co/UloCri1lFd

#IDTwitter #idxposts

[CMI Communications @CMIComms]

We are so excited for our next #Communicable episode on #newantibiotics dropping in 2 days, we're sharing another teaser!

You can find all of our episodes on your favorite podcast platform (Spotify, Apple, Youtube, etc) & on our #CMIComms homepage https://t.co/TDIWPu2mjL

[ESCMID @ESCMID]

We have teamed up with @IDSAInfo to publish this call to action before the #AMR high-level meeting at the UN General Assembly #UNGA. Bold targets and practical steps needs to be adopted on a policy level to address this global health crisis. Read the full commentary in @CMIComms

[ACCP INFD PRN @accpinfdprn]

Calling all #IDPRN and @SIDPharm members!! Are you or a team member presenting at #IDWeek2024 or #ACCPAM24?

Please complete the following surveys so we can highlight your work 🤓💊

🌟ID Week: https://t.co/Ef8cNQnmvS (DUE 9/27)

🌟ACCP: https://t.co/pWsRdKu23n (DUE 10/4)

[Contagion @Contagion_Live]

In our latest Bench to Bedside column from @SIDPharm @JRBPharmD and @vivianytsai discuss using long-acting lipoglycopeptides (LGPs) for a variety of infections.

Read the article here:
https://t.co/9y2yoYaUlI

[Emily McDonald @DrEmilyMcD]

Calling all #IDTwitter peeps! Please help us by filling out this thought provoking survey on diagnosis and management of CDI!!

@ABsteward @CMIComms @CMIJournal

[CMI Communications @CMIComms]

Our next #Communicable episode on pipeline #antibiotics is dropping Monday. Swipe for a preview of what’s in store for you!

@ErinMcCreary @MikeMndudley @Qpexbio @EMA_News @ESCMID
#IDtwitter #IDxposts #CMIComunications #OpenAccess